Inhibition of acalabrutinib metabolism by finerenone and its molecular docking studies.

Saved in:
Bibliographic Details
Title: Inhibition of acalabrutinib metabolism by finerenone and its molecular docking studies.
Authors: Wang P; The First Affiliated Hospital of Wenzhou Medical University, Zhejiang, China.; Zhejiang Key Laboratory of Intelligent Cancer Biomarker Discovery and Translation, First Affiliated Hospital, Wenzhou Medical University, Zhejiang, China., Fu H; The First Affiliated Hospital of Wenzhou Medical University, Zhejiang, China.; Zhejiang Key Laboratory of Intelligent Cancer Biomarker Discovery and Translation, First Affiliated Hospital, Wenzhou Medical University, Zhejiang, China., Wu J; The First Affiliated Hospital of Wenzhou Medical University, Zhejiang, China., Li R; The First Affiliated Hospital of Wenzhou Medical University, Zhejiang, China., Cao L; The First Affiliated Hospital of Wenzhou Medical University, Zhejiang, China., Xu RA; The First Affiliated Hospital of Wenzhou Medical University, Zhejiang, China. xra@wmu.edu.cn.; Zhejiang Key Laboratory of Intelligent Cancer Biomarker Discovery and Translation, First Affiliated Hospital, Wenzhou Medical University, Zhejiang, China. xra@wmu.edu.cn., Lin W; The First Affiliated Hospital of Wenzhou Medical University, Zhejiang, China. linweihong@wmu.edu.cn.
Source: Cell biology and toxicology [Cell Biol Toxicol] 2026 Feb 11; Vol. 42 (1). Date of Electronic Publication: 2026 Feb 11.
Publication Type: Journal Article
Journal Info: Publisher: Springer Country of Publication: Switzerland NLM ID: 8506639 Publication Model: Electronic Cited Medium: Internet ISSN: 1573-6822 (Electronic) Linking ISSN: 07422091 NLM ISO Abbreviation: Cell Biol Toxicol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1573-6822
DOI:10.1007/s10565-026-10148-5